“No one size fits all.” — Dr. Vijaya Surampudi, associate director of the UCLA Medical Weight Management Clinic, on ...
“That’s how it works.” Dr. Laura Davisson, director of the Medical Weight Management program at West Virginia University who ...
Novo Nordisk A/S (NYSE:NVO) is advancing its research on a pioneering hybrid drug, CagriSema. This drug merges semaglutide ...
The drugmaker hopes to show CagriSema leads to at least 25% weight loss, without increased side effects. Its lead in a ...